Based on a May 3, 2023, Congress will hold a public hearing on "Policies that Inhibit Innovation and Patient Access," under the House Ways & Means committee.
See the press release here:
The hearing will be live-streamed and (normally) the video is archived as well. Often, since this hearings arise suddenly, the House committee may accept comments after the hearing as well. This is open to May 24: WMSubmission@mail.house.gov
The live stream will be a hearing page, with agenda and personnel, that will be created at the W&M committee. https://waysandmeans.house.gov/ - keep checking:
Witness List
Mr. Tony Gonzales
National Early-Stage Advisor, Alzheimer’s Association
Mr. Ted Okon
Executive Director, Community Oncology Alliance
Dr. Darius Lakdawalla
Professor of Pharmaceutical Economics and Public Policy, USC Leonard D. Schaeffer Center for Health Policy & Economics
Dr. Joshua Makower, M.D.
Director, Stanford Byers Center for Biodesign, Stanford University
Dr. Aaron S. Kesselheim MD, JD, MPH
Professor of Medicine, Harvard Medical School
__
Recall that Congress had hearings on antibiotic resistance and on CMS policy, in the last ten days, my blog and link collections here.
